{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 43,
        "end": 51
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 62,
        "end": 65
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 95,
        "end": 112
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "21642685_12",
  "text": "CONCLUSIONS : Among patients with advanced melanoma harboring KIT alterations , treatment with imatinib mesylate results in significant clinical responses in a subset of patients ."
}
